TP53 and cancer: This may be of particular interest in DNA damage response (Nemajerova et al., 2018; Parrales et al., 2018), cell cycle arrest (Engeland, 2018; Wu and Prives, 2018), tumor suppression (Charni et al., 2018; Kaiser and Attardi, 2018) and in particular in cancer progression (Aubrey et al., 2018; Baugh et al., 2018; Kim and Lozano, 2018), when considering the pivotal role of p53 in these molecular mechanisms (Furth and Aylon, 2017; Furth et al., 2018; Sullivan et al., 2018).